DiaMedica Therapeutics Inc.
DMAC
$5.67
-$0.13-2.24%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.11% | -17.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.08% | -1.79% | |||
| Operating Income | -22.08% | 1.79% | |||
| Income Before Tax | -22.59% | 0.62% | |||
| Income Tax Expenses | 0.00% | 0.00% | |||
| Earnings from Continuing Operations | -22.56% | 0.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.56% | 0.62% | |||
| EBIT | -22.08% | 1.79% | |||
| EBITDA | -22.12% | 1.83% | |||
| EPS Basic | -9.14% | 0.88% | |||
| Normalized Basic EPS | -9.18% | 0.94% | |||
| EPS Diluted | -9.14% | 0.88% | |||
| Normalized Diluted EPS | -9.18% | 0.94% | |||
| Average Basic Shares Outstanding | 12.30% | 0.29% | |||
| Average Diluted Shares Outstanding | 12.30% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
